You're reading the free version. Trader adds the live tape and alerts.
Start tracking
ORKA Sale Disclosure
Goncalves Joana · SEC Form 4 · Filed Aug 17, 2026
Sale
Calculated transaction value
$371.89K
Goncalves Joana Chief Medical Officer
ORKA
Oruka Therapeutics
ORKA
Transaction date
Aug 17, 2026
Public filing date
Aug 17, 2026
Filing lag
Filed same day
ORKA daily price context
Close on/before transaction
$112.66
Aug 17, 2026
First close after public filing
$113.08
Aug 18, 2026
30-day return after filing
-17.27%
Through Sep 16, 2026
Source details
- Reported owner
- Not disclosed
- Source asset code
- Security
- Security
- Common Stock
- Quantity / price
- 3,320 shares @ $112.01
- SEC ownership
- Direct
- Transaction code
- S
- Form
- 4
- Filing identifier
- 0000907654-26-000079
Filing cohort
Transactions in this filing
Showing 8 of 8
Trades
8
Issuers
1
Estimated value
$834.12K
Buys / sales
0 / 4
| Issuer | Transaction | Traded | Value |
|---|---|---|---|
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 17, 2026 | $23.94K |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 17, 2026 | $98.69K |
| Oruka Therapeutics, Inc. ORKA Current | Sale | Aug 17, 2026 | $371.89K |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 17, 2026 | $279.15K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 17, 2026 | $0 |
| Oruka Therapeutics, Inc. ORKA | Sale | Aug 17, 2026 | $33.16K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 17, 2026 | $27.3K |
| Oruka Therapeutics, Inc. ORKA | Exercise | Aug 17, 2026 | $0 |